Back
GeneDx Holdings 10K Form
Buy
58
WGS
GeneDx Holdings
Last Price:
22.36
Seasonality Move:
-0.59%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive WGS News And Ratings
See the #1 stock for the next 7 days that we like better than WGS
WGS Financial Statistics
Sales & Book Value
| Annual Sales: | $202.57M |
|---|---|
| Cash Flow: | $-16.86M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $7.93 |
| Price / Book: | 2.62 |
Profitability
| EPS (TTM): | -5.18000 |
|---|---|
| Net Income (TTM): | $-135.02M |
| Gross Margin: | $90.01M |
| Return on Equity: | -51.37% |
| Return on Assets: | -29.97% |
GeneDx Holdings Earnings Forecast
Key GeneDx Holdings Financial Ratios
- The Gross Profit Margin over the past 5 years for WGS is 44.43%.
- The Selling, General & Administrative Expenses for WGS have been equal to 96.12% of Gross Profit Margin.
- The Research & Development expenses have been 28.76% of Revenue.
- The Interest Expense is -0.58% of Operating Income.
- The Net Earning history of WGS is -86.77% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 2 years.
GeneDx Holdings Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | WGS |
| Website: | genedx.com |
Debt
| Debt-to-Equity Ratio: | 0.25 |
|---|---|
| Current Ratio: | 3.22 |
| Quick Ratio: | 2.8 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
WGS Technical Analysis vs Fundamental Analysis
Buy
58
GeneDx Holdings (WGS)
is a Buy
Is GeneDx Holdings a Buy or a Sell?
-
GeneDx Holdings stock is rated a Buy
The current GeneDx Holdings [WGS] share price is $22.39. The Score for WGS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.